Literature DB >> 10740225

N-methyl-D-aspartate (NMDA) receptors in the ventral tegmental area: subcellular distribution and colocalization with 5-hydroxytryptamine(2A) receptors.

J J Rodríguez1, M D Doherty, V M Pickel.   

Abstract

Glutamate receptors of the N-methyl-D-aspartate (NMDA) subtype have been implicated in behavioral sensitization to psychostimulants and in psychotic behaviors involving excitation of ventral tegmental area (VTA) dopaminergic neurons. Antagonists of serotonin (5-hydroxytryptamine, 5-HT) receptors of the 5-HT(2A) subtype are potent antipsychotics that attenuate these NMDA-evoked responses. We examined the electron microscopic immunocytochemical localization of antisera against the NMDA R1 subunit (NMDAR1) and 5-HT(2A) receptors to determine potential sites for their dual activation in the rat paranigral and parabrachial VTA subdivisions that are distinguished, in part, by their respective striatolimbic and cortical projections. In both regions, NMDAR1 immunoreactivity was localized mainly to the cytoplasm of somata and dendrites, and was only occasionally seen near or within excitatory-type asymmetric synapses. Many of the NMDAR1-labeled somata and dendrites also expressed 5-HT(2A) receptors, having a similar, but largely non-overlapping, neuronal distribution. The mean area density of NMDAR1 and dually labeled dendritic profiles was significantly greater in the paranigral than in the parabrachial VTA. NMDAR1 was also present in small axons showing a similar regional difference in area density. No regional difference in area density was seen in dendrites or small axons containing only 5-HT(2A) receptors. Our results indicate that NMDA and 5-HT(2A) receptors in the VTA are transiently expressed on synaptic plasma membranes of single neurons showing widespread cytoplasmic distributions of each of the receptors. They also suggest a major role for NMDA receptors in modulating the output of paranigral neurons and the release of transmitters from axons passing through this region. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10740225     DOI: 10.1002/(SICI)1097-4547(20000415)60:2<202::AID-JNR9>3.0.CO;2-J

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  9 in total

1.  A systematic investigation of the differential roles for ventral tegmentum serotonin 1- and 2-type receptors on food intake in the rat.

Authors:  Wayne E Pratt; Kara A Clissold; Peagan Lin; Amanda E Cain; Alexa F Ciesinski; Thomas R Hopkins; Adeolu O Ilesanmi; Erin A Kelly; Zachary Pierce-Messick; Daniel S Powell; Ian A Rosner
Journal:  Brain Res       Date:  2016-07-16       Impact factor: 3.252

2.  MK-801 infusions to the ventral tegmental area and ventromedial hypothalamus produce opposite effects on lordosis of hormone-primed rats.

Authors:  Sandra M Petralia; Joseph F DeBold; Cheryl A Frye
Journal:  Pharmacol Biochem Behav       Date:  2007-01-13       Impact factor: 3.533

3.  In the ventral tegmental area, G-proteins mediate progesterone's actions at dopamine type 1 receptors for lordosis of rats and hamsters.

Authors:  Sandra M Petralia; Cheryl A Frye
Journal:  Psychopharmacology (Berl)       Date:  2006-02-16       Impact factor: 4.530

Review 4.  Serotonin receptors represent highly favorable molecular targets for cognitive enhancement in schizophrenia and other disorders.

Authors:  Bryan L Roth; S Mohammad Hanizavareh; Andrew E Blum
Journal:  Psychopharmacology (Berl)       Date:  2003-12-02       Impact factor: 4.530

5.  Serotonin 2A receptors differentially contribute to abuse-related effects of cocaine and cocaine-induced nigrostriatal and mesolimbic dopamine overflow in nonhuman primates.

Authors:  Kevin S Murnane; Jake Winschel; Karl T Schmidt; LaShaya M Stewart; Samuel J Rose; Kejun Cheng; Kenner C Rice; Leonard L Howell
Journal:  J Neurosci       Date:  2013-08-14       Impact factor: 6.167

6.  Increased hippocampal CA1 density of serotonergic terminals in a triple transgenic mouse model of Alzheimer's disease: an ultrastructural study.

Authors:  H N Noristani; R S Meadows; M Olabarria; A Verkhratsky; J J Rodríguez
Journal:  Cell Death Dis       Date:  2011-09-15       Impact factor: 8.469

7.  Low Doses of Psilocybin and Ketamine Enhance Motivation and Attention in Poor Performing Rats: Evidence for an Antidepressant Property.

Authors:  Guy A Higgins; Nicole K Carroll; Matt Brown; Cam MacMillan; Leo B Silenieks; Sandy Thevarkunnel; Julia Izhakova; Lilia Magomedova; Ines DeLannoy; Edward M Sellers
Journal:  Front Pharmacol       Date:  2021-02-26       Impact factor: 5.810

Review 8.  Molecular targets for treating cognitive dysfunction in schizophrenia.

Authors:  John A Gray; Bryan L Roth
Journal:  Schizophr Bull       Date:  2007-07-07       Impact factor: 7.348

9.  The Resilient Phenotype Induced by Prophylactic Ketamine Exposure During Adolescence Is Mediated by the Ventral Tegmental Area-Nucleus Accumbens Pathway.

Authors:  Eric M Parise; Lyonna F Parise; Omar K Sial; Astrid M Cardona-Acosta; Trevonn M Gyles; Barbara Juarez; Dipesh Chaudhury; Ming-Hu Han; Eric J Nestler; Carlos A Bolaños-Guzmán
Journal:  Biol Psychiatry       Date:  2021-05-08       Impact factor: 12.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.